967
Participants
Start Date
August 15, 2018
Primary Completion Date
August 20, 2020
Study Completion Date
February 1, 2022
Modified genetic counseling
After participants at high risk for a hereditary cancer syndrome receive exome sequencing, they will receive modified genetic counseling to help them understand the results.
Traditional genetic counseling
After participants at high risk for a hereditary cancer syndrome receive exome sequencing, they will receive traditional genetic counseling to help them understand the results.
Denver Health, Denver
Kaiser Permanente Center for Health Research, Portland
National Human Genome Research Institute (NHGRI)
NIH
University of Washington
OTHER
Seattle Children's Hospital
OTHER
University of California, San Francisco
OTHER
Denver Health and Hospital Authority
OTHER
Emory University
OTHER
Dana-Farber Cancer Institute
OTHER
Columbia University
OTHER
Kaiser Permanente
OTHER